H1B Atlas
M

MAVIN TECHNOLOGIES, INC

LCA FY2024-FY2026 · PERM FY2024-FY2025 · USCIS Employer Data Hub 2023 · BLS OEWS May 2023

HQ: GAITHERSBURG, MD
NAICS: 541511

Observed USCIS Denial Signal: 33.3%

The 2023 USCIS Employer Data Hub shows a higher-than-average I-129 denial share for this employer. This is a historical filing signal, not a prediction for any individual petition.

Median Base Salary

$106,000

H-1B LCA Filings

6LCA records

USCIS I-129 History

66.7%
Higher denial signal

PERM Filings

6filings

Sponsorship Filing Signals

PERM Activity Ratio

50%

This is not an individual green-card conversion or success rate. It compares the employer PERM filing volume with H-1B LCA filing volume in the available public datasets.

Compensation Value

84% of Industry Median

The median H-1B LCA base wage filed by this employer is below the peer industry baseline used here.

Data caveat

Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally exclude equity, bonus, and benefits. The PERM Activity Ratio shown here is descriptive filing activity, not a green-card success or conversion rate.

Salary Distribution (Base)

$106,000
P25: $96,366
P75: $106,000
Min: $94,931Max: $116,459

Top Job Titles

Top Locations

Frequently Asked Questions

What is the median H1B salary at MAVIN TECHNOLOGIES, INC?
The median filed base salary for H-1B LCA records at MAVIN TECHNOLOGIES, INC is $106,000.
How many H-1B LCA filings did MAVIN TECHNOLOGIES, INC submit?
MAVIN TECHNOLOGIES, INC filed 6 Labor Condition Applications in the available LCA dataset.
What PERM activity is observed for MAVIN TECHNOLOGIES, INC?
MAVIN TECHNOLOGIES, INC has 6 PERM filings in the available PERM dataset. This is not an individual green-card success rate.
What are the most common H1B roles at MAVIN TECHNOLOGIES, INC?
The most common H1B roles at MAVIN TECHNOLOGIES, INC include: SOFTWARE DEVELOPER, DATA ENGINEER, PROJECT MANAGER.